Carregant...
Incidence of Tuberculosis Among HIV/HCV Coinfected Patients Receiving Hepatitis C Treatment with Pegylated Interferon And Ribavirin In Georgia
Treatment of hepatitis C is necessary for ensuring higher life expectancy among HIV/HCV co-infected patients. However antiviral treatment for chronic HCV infection with Pegylated interferon (PEG-IFN) and Ribavirin (RBV) is associated with a variety of side effects. In Georgia up to 22% of HIV-infect...
Guardat en:
| Publicat a: | Georgian Med News |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5113941/ https://ncbi.nlm.nih.gov/pubmed/27119828 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|